Nichimo Co., Ltd. FY2026 Analysis: Guidance Points to Strong Full-Year Recovery
Nichimo Co., Ltd. (TSE:8091) is a diversified Japanese corporation specializing in fishing nets, fishing gear, and seafood trading, with core revenue streams derived from marine operations and processed seafood, while actively nurturing its bio-business segment. For the full fiscal year ending March 2026, the company reported Revenue of JPY 139.8bn, up 4.4% year-over-year (YoY). However, profitability metrics showed significant contraction, with Operating Profit falling 8.1% YoY to JPY 2.76bn, and Net Profit declining 18.2% YoY to JPY 2.18bn.
| Metric | Full Year (JPY bn) | Previous Year (JPY bn) | YoY Change |
|---|---|---|---|
| Revenue | 139.8 | 133.9 | +4.4% |
| Operating Profit | 2.76 | 3.00 | -8.1% |
| Ordinary Income | 3.02 | 3.60 | -16.2% |
| Net Profit | 2.18 | 2.67 | -18.2% |
| Operating Margin | 2.0% | N/A | N/A |
| Equity Ratio | 37.8% | 36.4% | N/A |
Nichimo Co., Ltd. maintains a foundational position across the entire seafood supply chain—from catch to consumer—and is strategically expanding into bio-business development. The slight increase in Revenue suggests sustained demand and operational stability within its established seafood trading and processing segments. However, the substantial divergence between the 4.4% revenue growth and the 18.2% drop in Net Profit signals significant underlying pressure on the cost structure or non-operating expenses.
The primary narrative derived from these figures is one of revenue resilience masking profitability headwinds. The decline in Operating Profit, despite rising sales, points to margin compression, likely driven by persistent increases in raw material costs or elevated operational expenses that could not be fully passed on to consumers.
Next Year Guidance
The company has provided an optimistic outlook for the next fiscal year, projecting increases across all key metrics.
| Metric | Forecast (JPY bn) | vs. Current FY Actual |
|---|---|---|
| Revenue | 145.0 | - |
| Operating Profit | 3.20 | - |
| Ordinary Income | 3.60 | - |
| Net Profit | 2.60 | - |
The guidance suggests a positive trajectory for the coming year, with the projected Net Profit of JPY 2.60bn representing a substantial rebound from the current year’s JPY 2.18bn. This upward revision across the board indicates management’s strong conviction in a return to robust profitability.
Key Observations for International Investors
The most critical takeaway for international investors is the structural disconnect between top-line growth and bottom-line performance. While the company’s commitment to its “from the sea to the table” mission and diversification into bio-business remains evident, the current profitability metrics suggest that cost management and effective price transmission are paramount challenges.
Secondly, the improvement in the Equity Ratio to 37.8% signals a positive trend in the balance sheet’s solvency, reinforcing the company’s financial stability despite the recent profit contraction.
Finally, while the management’s forward guidance is highly positive, investors should monitor the execution risk associated with cost control. The ability to translate the projected revenue growth into margin expansion—as implied by the Operating Profit forecast—will be the key determinant of whether the company successfully navigates the current volatile commodity and supply chain environment.
Source: Original filing (TDnet) | 日本語版
This article is for informational purposes only and does not constitute investment advice. Financial figures are AI-extracted and may contain errors — always verify against the original filing.